Kettering University Associate Professor Lisa Gandy Publishes Influential Research in 'Cancer Cell'

Kettering University Associate Professor Lisa Gandy Publishes Influential Research in "Cancer Cell"

Kettering University announced today that Dr. Lisa Gandy, an Associate Professor of Computer Science, has published pioneering research in the esteemed journal "Cancer Cell." Her study focuses on the market migration trends of women medical researchers leaving academia.

Dr. Gandy's study addresses the critical underrepresentation of women as Principal Investigators in clinical trials, which she links to a corresponding reduction in women participating in these trials, ultimately affecting the quality of cancer care delivered to female patients. Leveraging her expertise in data science, particularly in natural language processing and machine learning, Dr. Gandy utilized LinkedIn data to trace the career movements of women in the field.

"Social sciences and data analysis really work hand in hand. For instance, in this paper, we explore statistical differences in grants received, papers published, and whether women stay in the clinical research space," Dr. Gandy said. "Now that we have shown there is a statistically significant difference, a social scientist can do interviews, etc, and really tease apart why these disparities exist."

Dr. Gandy's publication in "Cancer Cell" signifies a significant advancement in addressing critical issues in the oncology field and illustrates Kettering University's ongoing dedication to cutting-edge research and societal betterment.

About "Cancer Cell"

"Cancer Cell" is a preeminent journal within the scientific community dedicated to publishing pivotal advances in cancer research and oncology. The journal is committed to advancing our understanding of naturally occurring cancers, primarily focusing on manuscripts that offer significant insights into pressing questions in the field. It is known for its emphasis on translational research that bridges experimental science with clinical applications.

This journal seeks to publish studies that potentially set new cancer treatment, diagnosis, and prevention standards. It also seeks to highlight clinical investigations that introduce groundbreaking paradigms and studies that extend our understanding of cancer biology beyond findings from preclinical settings. Furthermore, "Cancer Cell" focuses on mechanism-based proof-of-principle clinical studies demonstrating how molecular and cellular mechanisms can be harnessed to combat cancer effectively.

Maintaining a rigorous selection process and upholding high scientific standards, "Cancer Cell" contributes profoundly to advancing cancer research, ensuring that each publication enhances our collective capability to fight cancer more effectively.